Kristina Burow's Net Worth

$378 Million

Who is Kristina Burow?

Kristina Burow has an estimated net worth of $378 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Receptos, Inc., Neumora Therapeutics, Inc., DA32 Life Science Tech Acquisition Corp., Gossamer Bio, Inc., Scholar Rock Holding Corp, Erasca, Inc., Verve Therapeutics, Inc., Vir Biotechnology, Inc., Beam Therapeutics Inc., Metacrine, Inc., Unity Biotechnology, Inc., Sienna Biopharmaceuticals, Inc., and Prime Medicine, Inc..

SEC CIK

Kristina Burow's CIK is 0001569248

Past Insider Trading and Trends

2023 was Kristina Burow's most active year for acquiring shares with 29 total transactions. Kristina Burow's most active month to acquire stocks was the month of August. 2021 was Kristina Burow's most active year for disposing of shares, totalling 33 transactions. Kristina Burow's most active month to dispose stocks was the month of April. 2023 saw Kristina Burow paying a total of $31,430,024.08 for 19,579,375 shares, this is the most they've acquired in one year. In 2015 Kristina Burow cashed out on 1,420,308 shares for a total of $5,931,588.00, their largest year based on trade value.